Cases & Deals

Merck develops global patent portfolio related to certain antibodies for treatment of cognitive disorders

Clients Merck & Co., Inc.

Jones Day is representing Merck & Co., Inc. in the development and prosecution of global patent portfolios related to certain antibodies that are being developed for the treatment and prevention of various cognitive disorders.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.